Alzheimer’s Disease Expert Says Future Treatment Success Will Require a Shift in Strategy and Timing
Rudy Tanzi, PhD,future success in treating Alzheimer’s disease will come from earlier diagnosis and treatment guided by an individual’s family history and genetic risk factors.
The second annual Neuroscience Day took place under the Bulfinch tent earlier this month, with a series of speakers, research presentations and an electronic poster session highlighting recent advances.
What if there was a simple way to help individuals prioritize their emotional health just as much as their physical health? As a clinical psychology intern at Massachusetts General Hospital over a decade ago, Ana-Maria Vranceanu, PhD, found herself asking this question about the orthopedic surgery patients she was caring for.
Buckner’s Death Puts New Focus on Lewy Body Dementia—A Relatively Unknown but Surprisingly Prevalent Disease
Stephen Gomperts, MD, PhD, a physician-investigator in the Department of Neurology at Massachusetts General Hospital, explains that LBD is actually an umbrella term for two different diseases—one is dementia with Lewy bodies (LBD) and the other is Parkinson’s disease with dementia, which afflicts about 30% of people with Parkinson’s disease (PD).
A research project led by Massachusetts General Hospital’s Deepak Vijaya Kumar, PhD, will seek to untangle the connections between microbes in the gut and the onset of Alzheimer’s disease.
Researchers at Massachusetts General Hospital recently conducted a study to identify the factors that contribute to emotional stress after stroke, identify tools and strategies that would provide the most help, and determine an effective timeline and delivery system for an intervention program aimed at preventing chronic depression, anxiety and post traumatic stress in this high risk population.
Rare diseases can be very complex to treat due to lack of understanding, little to no options for treatment and limited funding. But it is for these reasons that raising awareness and supporting research and funding for rare diseases is so important. In honor of Rare Disease Day this year, we are highlighting a rare disease called neuromyelitis optica (NMO).
How a Dedicated Mass General Team Became the First to Discover Circulating Brain Tumor Cells in the Blood
Mass General researchers Shannon Stott and Brian Nahed have been working together for 10 years, and used their different backgrounds to their advantage to be the first to identify circulating brain tumor cells in the blood.
A team of researchers from Massachusetts General Hospital are exploring the role of lifestyle factors such as stress in the onset and progression of Alzheimer’s disease.
A team of researchers at Mass General, in collaboration with a team form the Karolinska Institutet in Sweden, recently identified a pattern of brain inflammation in the brains of fibromyalgia patients that could be the key to diagnosing this elusive disorder.